Home
overview

SAE Media Group and Medical Design Briefs Present
Biosensors for Medical Wearables
October 23-24, 2023 | Boston, MA, USA
-------------------------------------------------------------------------------------------

SAE Media Group’s 3rd Annual Biosensors for Medical Wearables Conference will be back for 2023 in Boston to bring together device developers, MedTech, component manufacturers and big pharma to share and discuss the exciting advances in the medical wearable technology landscape.


The wearable biosensors market has grown significantly in recent years leading to increasingly growing potential for medical applications and at home alternatives for patients. With growing applications and potential in remote patient monitoring, diagnosis, therapeutics and detection of disease, wearable sensors are attracting considerable interest due to their opportunities in better supporting patients, clinical outcomes and decisions. Furthermore, AI and connected technologies are furthering the potential opportunities of this industry. However, challenges including flexibility of wearable devices, the collection of clinical-grade data and advanced battery technologies still remain for the industry to overcome. This year’s conference looks to address these hot topics through case studies and industry insights.


This is a must attend event, giving you the chance to engage in the latest innovations that are accelerating the wearable biosensors industry. We hope to welcome you in October 2023!
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 

  • Benchmark against and explore the latest biosensor technologies for wearable medical devices from Abbott, Empatica and Hexoskin
  • Delve into the potential of wearable sensors and digital tools in decentralized diagnosis including a Johnson & Johnson case study on the Heartline project
  • Learn how game changing companies such as Philips and Medtronic are utilizing wearables to maximize remote patient monitoring opportunities for wider patient populations
  • Explore how AI and machine learning technologies are enabling optimized data collection and streamlined data analysis
  • Discover cutting-edge biosensor therapeutic applications for neurology with Neurasantys and a panel discussion on future medical opportunities

 

Executives, Directors, VPs, Heads, Principals, Managers of:

  • Advanced Technology R&D
  • Biosensor Device Engineering
  • Biosensor Development
  • Connected Device Engineering
  • Connected Device Development
  • Medical Device Development
  • Diagnostic Devices
  • Digital Health Technologies
  • Digital Medicine
  • Digital Therapeutics
  • Emerging Technology R&D
  • Patient Monitoring System Development
  • Regulatory Affairs and Digital Health
  • Regulatory Affairs Diagnostics and Digital Health
  • Strategic Partnerships
  • Wearable Device Development
  • Wearable Device Engineering

AbbVie; ActiGraph; AstraZeneca; Beacon Biosignals; Biofourmis; Biogen; BioIntelliSense, Inc.; Bloomer Tech; Boston University; Boston University, Chobanian & Avedisian School of Medicine; CALA; CardioSignal Inc; Colgate Palmolive Company; Cosinuss; Digital Medicine Society; Focus Academy; Haleon; Haydale Limited; Hexoskin; I-Mab BioPharma US; Lohmann Americas; Massachusetts General Hospital; Medical Design Briefs; MedRhythms; Moffitt Cancer Center; Movesense Ltd; Neursantys, Inc.; Oracle Health Sciences; Pennslyvania State University; Pfizer Inc; PyrAmes, Inc; Qura, Inc; Raudmedic AG; Rockley Photonics; Sanofi; Simbex; Spacelabs Healthcare; Takeda; Takeda Pharmaceuticals; TechBlocks Inc; TracPatch Health; Valencell; Wurq;

Conference agenda

clock

8:00

Registration & Coffee

clock

9:00

Co- Chair's Opening Remarks

Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

clock

9:10

Biowearables: Evolution and vision for harnessing direct real-time internal biomarker data from our bodies

Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

  • Overview of the evolution of bio/wearables technology
  • Insights on continuous biomarker monitoring of interstitial fluid (ISF) as it relates to health and disease
  • Personalized data driven technologies and what they mean to the future of consumer-led healthcare
     
  • clock

    9:50

    Non-Adhesive, Flexible Wearable Sensors for Pulmonary Medical Applications

    Pierre-Alexandre Fournier, Co-founder/CEO, Hexoskin

  • Utilising smart clothing for pulmonary medical applications and reviewing the challenges to be overcome for long-term wearables
  • Exploring digital biomarkers for pulmonary conditions including COPD, asthma and chronic cough
  • Delving into the collection and processing of data from the smart garment monitoring platform
  • Leveraging collaborations with universities and research hospitals to further research and advance the potential of long-term sensor technologies
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Panel Discussion: Evolving Digital Medical Opportunities and Emerging Technologies

  • Insight into new therapeutic applications of biosensors and emerging uses
  • How can industry work together to accelerate and further opportunities in medical biosensors and connected devices
  • Advancing how data is used to enhance patient care and diagnostics
  • Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Venk Varadan, CEO and Co-founder, Nanowear

    Alicia Chong Rodriguez, CEO, Bloomer Tech

    Grant Weller, SVP Data Science, BioIntelliSense, Inc.

    clock

    11:40

    Transforming Health Monitoring with the use of Medical-Grade Technologies

    Jason Case, Vice President, Research & Development, Patient Monitoring, Medtronic

  • Overview of challenges and opportunities for monitoring patients as they shift from higher acuity settings in the hospital to lower acuity settings, and eventually, back home
  • Overview of the Medtronic Patient Monitoring business, including the technology portfolio, and why medical-grade technologies are so important to address challenges in the patient monitoring space
  • Discuss how current medical-grade solutions solve the issue of the “monitoring cliff” when patients shift to different settings in the hospital and when they are discharged home (multiparameter wearable, connected data capture and visualization)
  • Address future technological applications to better capture vitals and important patient biomarkers anytime, anywhere
  • clock

    12:20

    Networking Lunch

    clock

    13:20

    Medical Grade Monitoring in Hospital to Home

    Grant Weller, SVP Data Science, BioIntelliSense, Inc.

  • Current state of device wearables capabilities in hospital and at home
  • How medical grade monitoring impacts/assists healthcare staff
  • Future of medical grade wearables from in hospital to home
  • clock

    14:00

    Heartline Study: Evolving Digital Clinical Evidence Generation

    Janet Nikolovski, New Venture Lead, Johnson & Johnson

  • Background on the Heartline study and update on current status
  • Utilizing direct to patient enrolment and engagement in remote studies with digital tools
  • Practices for enhancing patient engagement and allowing the patient to work with healthcare providers to understand how to reduce risks
  • Assessing key learnings from the heartline study so far and looking at steps moving forwards

     

  • clock

    14:40

    Afternoon Tea

    clock

    15:10

    Transforming Remote Care Models in Heart Diseases with Motion-Sensor Technology

    Catherine Liao, Chief Strategy Officer, CardieX

  • Cardiovascular diseases are a growing burden, and delayed diagnostics leaves many at-risk patients vulnerable to adverse health outcomes. In this presentation, we introduce how a novel motion sensor technology, gyrocardiography, can be utilized to improve care paths in cardiovascular care
  • Examples include care models in population health, remote patient monitoring and point-of-care diagnostics
  • Opportunities in clinical trials and patient identification will also be discussed
  • Presenting a case example in heart failure, and what the standard of care looks like in the future
  • clock

    15:50

    Wearables for the Diagnosis and Monitoring of Cardiovascular Diseases

    Branislav Vajdic, Founder and CEO, HeartBeam

  • Case study on a sensor that is designed for heart attack detection
  • Design strategies for production of a patient-friendly device to monitor pressure changes in the heart
  • Ensuring accuracy and a high threshold for statistically significant data
  • Exploring how the biosensor has improved cardiac patient monitoring so far and potential future applications for similar devices
  • clock

    16:30

    Co-Chair’s Closing Remarks and Close of Day One

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Co- Chair's Opening Remarks

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Lorelie H. Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (An Abbott Company)

    clock

    9:10

    Effective and Efficient Use of Wearables for Decentralised Clinical Trials

    Tim Callahan, VP Scientific Affairs, Philips Pharma Solutions

  • Maximising the developments in wearable technologies and bolstering capabilities for decentralised clinical trials
  • Best practises and strategies for a successful decentralised clinical trial design
  • What steps still need to be made before decentralized clinical trials are adopted into healthcare strategy?
  • Case study on ePatch: delivering continuous, ECG data for 24 hours and up to 14 days
  • Utilising cloud-based software powered by AI to streamline ECG analysis
  • clock

    9:50

    Partnering with Pharma to Implement Biosensors in Clinical Trials

    Jasmin Imsirovic, Associate Director, Takeda

  • What are the unique needs of pharma clinical trials and how can they be met by partnering with wearables companies?
  • Selecting appropriate measures from biosensors and demonstrating scientific acumen through validation, regulatory clearance, or publication track record
  • Reducing the operational complexity of biosensors to improve clinical site and patient experience
  • Navigating the onboarding process and demonstrating clinical trial readiness as a vendor
     
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Advantages and challenges with clinical adoption of wearables

    Girish Gangadharan, VP, Strategy & Business Development, Spacelabs Healthcare

  • Usability and ubiquity of wireless sensing
  • Clinical evidence for implications on clinical workflow
  • Costs, and other operational considerations when considering wearables
  • clock

    11:40

    SoftPulse™ - best-in-class dry electrodes for wearables and their application in 3D-printed, fully personalized caps for brain recording and stimulation

  • SoftPulse™ rubber-based dry electrodes as best-in-class components for wearable devices
  • Properties and advantages of SoftPulse™ electrodes for bio-potential acquisition
  • 3D-printed wearable for perfect fit, stable electrical contact, designed for home use
  • Electrode positions fully customized for multi-focal stimulation and source EEG (tACS, tDCS, EEG)
     
  • Mattia Alberto Lucchini, Head of Wearable Sensors Development, Datwyler Switzerland Inc.

    Julius Klaas, CTO, Bottneuro AG

    clock

    12:20

    Speech Data Collection on Mobile Devices: Observations from a BOYD, Decentralized Clinical Trial

    Kara Chappie, Director and Project Lead, Pfizer

  • Considerations when collecting speech for acoustic analyses in a remote clinical trial
  • Preparing remote data for analyses: Did you collect the data you were expecting?
  • Are traditional speech acoustic features similar on varied devices?
  • clock

    13:00

    Networking Lunch

    clock

    14:00

    Healthcare-At-Home Device & Digital Solutions: Addressing and Managing All Stakeholders & When

    Venk Varadan, CEO and Co-founder, Nanowear

  • Discussing how remote diagnostics and clinical decision support utilizing AI and machine learning is now the prominent focus for all stakeholders in healthcare
  • Shedding light on how digital-only solutions are limited in the clinical and diagnostic services for dynamic data, particularly those utilizing AI and machine learning
  • Rethinking how device plus digital artificial intelligence and machine learning must be developed in parallel with all stakeholders in mind: patients, providers, regulators and payers
  • clock

    14:40

    From biosensor to endpoint: Building a full-stack digital biomarker platform to advance medical research

    Matteo Lai, CEO, Empatica

  • Incorporation of multiple sensors into a wearable device to derive PPG, electrodermal activity, temperature, accelerometer and gyroscope data
  • Ensuring ease-of use for patients and clinical trial participants through user-centric design
  • Developing and validating a digital biomarker portfolio
  • Applications: From scaling decentralized clinical trials to seizure detection for people living with epilepsy
  • clock

    15:20

    Afternoon Tea

    clock

    15:50

    Analysing and Interpreting Data Collected from Biometric Monitoring Technologies in Clinical Trials

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

  • What is needed from the device perspective for better data collection?
  • Ensuring data collected is medical grade and best practises for generating evidence for clinical validity
  • Exploring the regulatory pathways through which clinical validity evidence may be reviewed
  • Addressing the common pitfalls of dealing with data at scale in clinical research
  • Discussing the potential ways industry can use sensor generated data to make better, faster decisions
  • clock

    16:30

    Electroceuticals vs Pharmaceuticals

    Sameer Dhamne, Director, Clinical Affairs, Neursantys, Inc.

  • How are electroceuticals providing an alternative to pharmaceuticals? Cost considerations and more
  • Maximising the potential of neurostimulation techniques to counteract neurophysiological conditions and disease
  • Reviewing the challenges in the design and development of devices for neurostimulation delivery
  • Case studies on electroceutical applications: Balance decline, Parkinson’s disease, stroke, multiple sclerosis, depression, pain and more
  • clock

    17:10

    Co- Chair's Closing Remarks and Close of Day Two


    CEO
    Bloomer Tech
    Strategic Advisory Board
    Digital Medicine Society
    Founder and CEO
    HeartBeam
    Chief Strategy Officer
    CardieX
    VP, Strategy & Business Development
    Spacelabs Healthcare
    SVP Data Science
    BioIntelliSense, Inc.
    New Venture Lead
    Johnson & Johnson
    Associate Director
    Takeda
    Vice President, Research & Development, Patient Monitoring
    Medtronic
    CTO
    Bottneuro AG
    Director and Project Lead
    Pfizer
    Manager, Clinical Affairs
    Lingo Sensing Technology Unlimited Company (An Abbott Company)
    CEO
    Empatica
    Head of Wearable Sensors Development
    Datwyler Switzerland Inc.
    Co-founder/CEO
    Hexoskin
    Director, Clinical Affairs
    Neursantys, Inc.
    Chief Medical Officer and President, US Operations
    CardioSignal Inc
    VP Scientific Affairs
    Philips Pharma Solutions
    CEO and Co-founder
    Nanowear

    Sponsors

    Exhibitors

    VENUE

    Courtyard by Marriott Boston Downtown

    Boston, USA

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Preliminary Attendee List

    Download

    Speaker Interview: Andreas Caduff, Strategic Advisory Board, Digital Medicine Society

    Download

    Speaker Interview: Mattia Lucchini, Head of Wearable Sensors Development at Datwyler

    Download

    Speaker Interview: Tim Callahan, VP Scientific Affairs, Philips Pharma Solutions

    Download

    Speaker Interview: Janet Nikolovski, New Venture Lead, Johnson & Johnson

    Download

    Welcome from the Chairs

    Download

    Past Presentation: Eric Richardson, MedRhythms

    Download

    Past Attendee List

    Download

    Brochure

    Download

    Past Presentation: Orel Swenson, Biofourmis

    Download

    Sponsors


    Datwyler

    Sponsors
    https://datwyler.com/company/innovation/softpulse

    Datwyler is a leading manufacturer of system-critical elastomer components for advanced applications in healthcare, mobility, and other industries. Based on our core competencies solution design, material expertise, and operational excellence, we deliver customer value from idea to industrialization.

    SoftPulse™ soft dry electrodes are Datwyler solution for long-term and gel-free ExG monitoring. Our electrodes made from conductive elastomer offer high wear comfort thanks to the softness of the material. Dry signal acquisition without use of gel shortens preparation time and allows ambulatory ExG applications. Robust design and easy cleanability enable repeated use. The combination of superior materials and optimized production processes leads to best-in-class signal quality among soft dry electrodes with excellent stability against ageing and abrasion.

    SoftPulse™ are available in three standard designs. Thanks to Datwyler core competences, electrodes are produced using fully scalable manufacturing processes. Customization according to customer needs are as well possible for small and serial volumes.


    Exhibitors


    East West

    Exhibitors
    https://www.ewmfg.com/

    East West is a global manufacturing services company focused on the realization of products, from design through distribution. As specialists in onshore, nearshore, and offshore manufacturing, we offer a seamless path to scale and an exceptional speed-to-market strategy while driving down costs and adhering to the highest quality standards. We are one integrated family, working together to support our customers throughout the entire product lifecycle. Our vision is to make the world a better place – cleaner, safer, healthier and smarter. East West offers its customers solutions in automation and robotics, industrial technology, IoT and smart devices, biosensors, and medical wearables.



    Lohmann

    Exhibitors
    https://www.lohmann-tapes.us/us/site__264/?

    Lohmann is a privately held, German based company. We are a pressure sensitive adhesive manufacturer with converting capabilities. We have US based manufacturing sites in Hebron Kentucky and Orange Virginia. We manufacture backing materials and cover tapes for lateral flow along with component parts for wearable, ostomy, drape tapes and other medical related applications.


    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Courtyard by Marriott Boston Downtown


    USA

    Courtyard by Marriott Boston Downtown

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out